Agree with your points but would like to add to that. WHEN one or all three of the current active trial drugs make it successfully to a certain point (be it PHASE !!! completion or FDA approval) I would think NEW small investors will be the least of their worries. Just one BIG ONE would snap their hold. Still have the listing upgrade to look forward too also. A PPS over 5 can bring in a lot of institutions.